COMPASS THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
COMPASS THERAPEUTICS, INC. (CMPX) reported Basic Shares Outstanding (Weighted Average) of 186.80 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- COMPASS THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 186.80M shares, a 35.08% increase year-over-year.
- COMPASS THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 186.40M shares, a 34.84% increase year-over-year.
- COMPASS THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 185.15M shares, a 34.41% increase year-over-year.
- COMPASS THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 168.78M shares, a 22.67% increase year-over-year.
- COMPASS THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 157.69M shares, a 14.78% increase from fiscal 2024.
- COMPASS THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 137.38M shares, a 8.15% increase from fiscal 2023.
- COMPASS THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 127.03M shares, a 20.76% increase from fiscal 2022.
- COMPASS THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 105.19M shares, a 67.31% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 186.80M shares 10-Q · filed 2026-08-06 | 186.60M shares 10-Q · filed 2026-08-06 | 186.11M shares derived: average of 3 quarters · filed 2026-08-06 | 181.78M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 186.40M shares 10-Q · filed 2026-05-05 | 185.77M shares derived: average of 2 quarters · filed 2026-05-05 | 180.11M shares derived: average of 3 quarters · filed 2026-05-05 | 169.65M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 185.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 176.96M shares derived: average of 2 quarters · filed 2026-03-05 | 164.07M shares derived: average of 3 quarters · filed 2026-08-06 | 157.69M shares 10-K · filed 2026-03-05 |
| 2025-09-30 | 168.78M shares 10-Q · filed 2025-11-05 | 153.53M shares derived: average of 2 quarters · filed 2026-08-06 | 148.54M shares 10-Q · filed 2025-11-05 | 145.76M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 138.28M shares 10-Q · filed 2026-08-06 | 138.26M shares 10-Q · filed 2026-08-06 | 138.09M shares derived: average of 3 quarters · filed 2026-08-06 | 137.96M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 138.24M shares 10-Q · filed 2026-05-05 | 137.99M shares derived: average of 2 quarters · filed 2026-05-05 | 137.86M shares derived: average of 3 quarters · filed 2026-05-05 | 137.79M shares derived: average of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | 137.75M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 137.67M shares derived: average of 2 quarters · filed 2026-03-05 | 137.64M shares derived: average of 3 quarters · filed 2026-03-05 | 137.38M shares 10-K · filed 2026-03-05 |
| 2024-09-30 | 137.59M shares 10-Q · filed 2025-11-05 | 137.59M shares derived: average of 2 quarters · filed 2025-11-05 | 137.26M shares 10-Q · filed 2025-11-05 | 134.85M shares derived: average of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | 137.59M shares 10-Q · filed 2025-08-11 | 137.10M shares 10-Q · filed 2025-08-11 | 133.93M shares derived: average of 3 quarters · filed 2025-08-11 | 132.30M shares derived: average of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | 136.61M shares 10-Q · filed 2025-05-08 | 132.10M shares derived: average of 2 quarters · filed 2025-05-08 | 130.54M shares derived: average of 3 quarters · filed 2025-05-08 | 129.59M shares derived: average of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | 127.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 127.51M shares derived: average of 2 quarters · filed 2025-02-27 | 127.25M shares derived: average of 3 quarters · filed 2025-02-27 | 127.03M shares 10-K · filed 2025-02-27 |
| 2023-09-30 | 127.42M shares 10-Q · filed 2024-11-12 | 127.08M shares derived: average of 2 quarters · filed 2024-11-12 | 126.84M shares 10-Q · filed 2024-11-12 | 124.61M shares derived: average of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | 126.73M shares 10-Q · filed 2024-08-12 | 126.54M shares 10-Q · filed 2024-08-12 | 123.68M shares derived: average of 3 quarters · filed 2024-08-12 | 118.01M shares derived: average of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | 126.38M shares 10-Q · filed 2024-05-13 | 122.15M shares derived: average of 2 quarters · filed 2024-05-13 | 115.10M shares derived: average of 3 quarters · filed 2024-05-13 | 111.56M shares derived: average of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | 117.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | 109.47M shares derived: average of 2 quarters · filed 2024-03-21 | 106.63M shares derived: average of 3 quarters · filed 2024-03-21 | 105.19M shares 10-K · filed 2024-03-21 |
| 2022-09-30 | 101.01M shares 10-Q · filed 2023-11-09 | 100.98M shares derived: average of 2 quarters · filed 2023-11-09 | 100.94M shares 10-Q · filed 2023-11-09 | 97.32M shares derived: average of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | 100.95M shares 10-Q · filed 2023-08-03 | 100.90M shares 10-Q · filed 2023-08-03 | 96.09M shares derived: average of 3 quarters · filed 2023-08-03 | 87.49M shares derived: average of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | 100.86M shares 10-Q · filed 2023-05-04 | 93.66M shares derived: average of 2 quarters · filed 2023-05-04 | 83.01M shares derived: average of 3 quarters · filed 2023-05-04 | 75.23M shares derived: average of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | 86.47M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | 74.08M shares derived: average of 2 quarters · filed 2023-03-15 | 66.69M shares derived: average of 3 quarters · filed 2023-03-15 | 62.87M shares 10-K · filed 2023-03-15 |
| 2021-09-30 | 61.69M shares 10-Q · filed 2022-11-09 | 56.80M shares derived: average of 2 quarters · filed 2022-11-09 | 55.00M shares 10-Q · filed 2022-11-09 | |
| 2021-06-30 | 51.91M shares 10-Q · filed 2022-08-01 | 51.58M shares 10-Q · filed 2022-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |